16-89935235-C-T
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM2PM5PP2PP3_StrongPP5_Very_Strong
The ENST00000315491.12(TUBB3):c.784C>T(p.Arg262Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,454 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R262H) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000315491.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBB3 | NM_006086.4 | c.784C>T | p.Arg262Cys | missense_variant | 4/4 | ENST00000315491.12 | NP_006077.2 | |
TUBB3 | NM_001197181.2 | c.568C>T | p.Arg190Cys | missense_variant | 4/4 | NP_001184110.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TUBB3 | ENST00000315491.12 | c.784C>T | p.Arg262Cys | missense_variant | 4/4 | 1 | NM_006086.4 | ENSP00000320295.7 | ||
ENSG00000198211 | ENST00000556922.1 | c.1825C>T | p.Arg609Cys | missense_variant | 5/5 | 2 | ENSP00000451560.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461454Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727074
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden | Jun 20, 2023 | PS3, PP4, PP3, PM5, PS4, PM2_SUP - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 28, 2023 | Reported in unrelated patients with TUBB3-related CFEOM referred for genetic testing at GeneDx and in the published literature (Tischfield et al., 2010); Published functional studies demonstrate impaired microtubule function (Tischfield et al., 2010); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Missense variants in this gene are often considered pathogenic (HGMD); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28832562, 27428177, 29382549, 31226147, 20074521, 29453417, 24077912) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 03, 2021 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this variant affects TUBB3 protein function (PMID: 20074521). This variant has been observed in individual(s) with congenital fibrosis of the extraocular muscles type 3 (PMID: 20074521, 29453417). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. This variant is also known as p.Arg190Cys. ClinVar contains an entry for this variant (Variation ID: 6963). This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with cysteine at codon 262 of the TUBB3 protein (p.Arg262Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. - |
Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement Pathogenic:2Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Feb 02, 2022 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0104 - Dominant negative is a known mechanism of disease in this gene and is associated with congenital fibrosis of extraocular muscles 3A (MIM#600638) (PMID: 31219644). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to cysteine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0603 - Missense variant in a region that is highly intolerant to missense variation (high constraint region in DECIPHER). (SP) 0704 - Another missense variant comparable to the one identified in this case has previous evidence for pathogenicity (ClinVar). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This is a recurrent pathogenic variant associated with the milder form of congenital fibrosis of extraocular muscles (ClinVar, PMID: 20074521, 32573066). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 08, 2010 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at